Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03752866




Registration number
NCT03752866
Ethics application status
Date submitted
15/11/2018
Date registered
26/11/2018
Date last updated
18/01/2022

Titles & IDs
Public title
The CONFIDENCE Registry
Scientific title
CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence
Secondary ID [1] 0 0
SJM-CIP-CL1003491
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Symptomatic Degenerative Aortic Stenosis 0 0
Severe Aortic Stenosis 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Diseases of the vasculature and circulation including the lymphatic system
Other 0 0 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Portico™ Valve, Portico Delivery System(s) and Loading Systems(s)
Treatment: Devices - Portico™ Valve, FlexNav Delivery System(s) and Loading Systems(s)

Experimental: Portico™ Valve, Delivery System(s) and Loading Systems(s) - Implantation of the Portico ™ Valve using the Portico Delivery and Loading Systems

Experimental: Portico™ Valve, FlexNav Delivery and Loading System(s) - Implantation of the Portico ™ Valve using the FlexNav Delivery and Loading Systems


Treatment: Devices: Portico™ Valve, Portico Delivery System(s) and Loading Systems(s)
Subjects will undergo implantation of a commercially available Portico transcatheter aortic heart valve using the Portico TAVI system

Treatment: Devices: Portico™ Valve, FlexNav Delivery System(s) and Loading Systems(s)
Subjects will undergo implantation of a commercially available Portico transcatheter aortic heart valve using the FlexNav Delivery and Loading Systems
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Cardiovascular Mortality
Timepoint [1] 0 0
30 days from the index procedure

Eligibility
Key inclusion criteria
* Subjects who are >18 years of age or legal age in host country and have been identified as a candidate for a Portico™ valve implant
* Subjects who have been informed of the nature of the study, agree to its provisions and have provided written informed consent as approved by the Ethics Committee (EC) of the respective clinical center
Minimum age
18 Years
Maximum age
100 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Candidates will be excluded if any of the following conditions are present:

1. Have sepsis, including active endocarditis
2. Have any evidence of left ventricular or atrial thrombus
3. Have vascular conditions (i.e. caliber, stenosis, tortuosity, or severe calcification) that make insertion and endovascular access to the aortic valve improbable
4. Have a non-calcified aortic annulus
5. Have congenital bicuspid or unicuspid leaflet configuration
6. Are unable to tolerate antiplatelet/anticoagulant therapy
7. Are pregnant at the time of signing informed consent
8. Are currently participating in a drug or device study that may impact the registry (unless prior sponsor approval for co-enrollment is granted)

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
UNKNOWN
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
25/10/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
30/12/2022
Actual
Sample size
Target
Accrual to date
Final
1001
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 0 0
Heart Care Partners- Wesley Hospital - Woolloongabba
Recruitment postcode(s) [1] 0 0
4102 - Woolloongabba
Recruitment outside Australia
Country [1] 0 0
Belgium
State/province [1] 0 0
Antwerpen
Country [2] 0 0
Czechia
State/province [2] 0 0
Olomouc
Country [3] 0 0
Germany
State/province [3] 0 0
Bavaria
Country [4] 0 0
Germany
State/province [4] 0 0
Bad Nauheim
Country [5] 0 0
Germany
State/province [5] 0 0
Berlin-Mitte
Country [6] 0 0
Germany
State/province [6] 0 0
Berlin
Country [7] 0 0
Germany
State/province [7] 0 0
Dortmund
Country [8] 0 0
Germany
State/province [8] 0 0
Dresden
Country [9] 0 0
Germany
State/province [9] 0 0
Frankfurt
Country [10] 0 0
Germany
State/province [10] 0 0
Hamburg
Country [11] 0 0
Germany
State/province [11] 0 0
Karlsruhe
Country [12] 0 0
Germany
State/province [12] 0 0
Mainz
Country [13] 0 0
Italy
State/province [13] 0 0
Lombardy
Country [14] 0 0
Italy
State/province [14] 0 0
Milano
Country [15] 0 0
Italy
State/province [15] 0 0
San Donato Milanese
Country [16] 0 0
Italy
State/province [16] 0 0
Vicenza
Country [17] 0 0
Poland
State/province [17] 0 0
Mazovia
Country [18] 0 0
Spain
State/province [18] 0 0
Catalonia
Country [19] 0 0
Spain
State/province [19] 0 0
Huelva
Country [20] 0 0
Spain
State/province [20] 0 0
Madrid
Country [21] 0 0
Switzerland
State/province [21] 0 0
Aarau
Country [22] 0 0
United Kingdom
State/province [22] 0 0
Ireland
Country [23] 0 0
United Kingdom
State/province [23] 0 0
North East England
Country [24] 0 0
United Kingdom
State/province [24] 0 0
Swansea
Country [25] 0 0
United Kingdom
State/province [25] 0 0
London

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Abbott Medical Devices
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Helge Möllmann
Address 0 0
St. Johannes Hospital, Dortmund, Germany
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT03752866